skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Base de dados/Biblioteca: IngentaConnect Journals remover nível superior: Revistas revisadas por pares remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors
Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors
Material Type:
Artigo 		Adicionar ao Meu Espaço

Severe Pulmonary Toxicity After Myeloablative Conditioning Using Total Body Irradiation: An Assessment of Risk Factors

Kelsey, Chris R., M.D ; Horwitz, Mitchell E., M.D ; Chino, Junzo P., M.D ; Craciunescu, Oana, Ph.D ; Steffey, Beverly, M.S ; Folz, Rodney J., M.D. Ph.D ; Chao, Nelson J., M.D ; Rizzieri, David A., M.D ; Marks, Lawrence B., M.D

International journal of radiation oncology, biology, physics, 2011-11, Vol.81 (3), p.812-818 [Periódico revisado por pares]

New York, NY: Elsevier Inc

Texto completo disponível

Citações Citado por
2
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation
Material Type:
Artigo 		Adicionar ao Meu Espaço

Posttransplant lymphoproliferative disorder following nonmyeloablative allogeneic stem cell transplantation

SNYDER, Matthew J ; STENZEL, Timothy T ; BUCKLEY, Patrick J ; LAGOO, Anand S ; RIZZIERI, David A ; GASPARETTO, Cristina ; VREDENBURGH, James J ; CHAO, Nelson J ; GONG, Jerald Z

The American journal of surgical pathology, 2004-06, Vol.28 (6), p.794-800 [Periódico revisado por pares]

Hagerstown, MD: Lippincott Williams & Wilkins

Texto completo disponível

Citações Citado por
3
Zevalin® (ibritumomab tiuxetan): After More Than a Decade of Treatment Experience, What Have We Learned?
Zevalin® (ibritumomab tiuxetan): After More Than a Decade of Treatment Experience, What Have We Learned?
Material Type:
Artigo 		Adicionar ao Meu Espaço

Zevalin® (ibritumomab tiuxetan): After More Than a Decade of Treatment Experience, What Have We Learned?

Rizzieri, David

Critical reviews in oncology/hematology, 2016-09, Vol.105, p.5-17 [Periódico revisado por pares]

Netherlands: Elsevier Ireland Ltd

Texto completo disponível

Citações Citado por
4
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Disabling Immune Tolerance by Programmed Death-1 Blockade With Pidilizumab After Autologous Hematopoietic Stem-Cell Transplantation for Diffuse Large B-Cell Lymphoma: Results of an International Phase II Trial

ARMAND, Philippe ; NAGLER, Arnon ; FAY, Joseph W ; RIZZIERI, David A ; HOSING, Chitra M ; BALL, Edward D ; UBERTI, Joseph P ; LAZARUS, Hillard M ; MAPARA, Markus Y ; GREGORY, Stephanie A ; TIMMERMAN, John M ; ANDORSKY, David ; WELLER, Edie A ; OR, Reuven ; WALLER, Edmund K ; ROTEM-YEHUDAR, Rinat ; GORDON, Leo I ; DEVINE, Steven M ; AVIGAN, David E ; CHEN, Yi-Bin ; KAMINSKI, Mark S ; KENT HOLLAND, H ; WINTER, Jane N ; MASON, James R

Journal of clinical oncology, 2013-11, Vol.31 (33), p.4199-4206 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
5
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure
Material Type:
Artigo 		Adicionar ao Meu Espaço

Hematopoietic Stem-Cell Transplantation for Acute Leukemia in Relapse or Primary Induction Failure

DUVAL, Michel ; KLEIN, John P ; KEATING, Armand ; LAZARUS, Hillard M ; LITZOW, Mark R ; MARKS, David I ; MAZIARZ, Richard T ; RIZZIERI, David A ; SCHILLER, Gary ; SCHULTZ, Kirk R ; TALLMAN, Martin S ; WEISDORF, Daniel ; WENSHENG HE ; CAHN, Jean-Yves ; CAIRO, Mitchell ; CAMITTA, Bruce M ; KAMBLE, Rammurti ; COPELAN, Edward ; DE LIMA, Marcos ; GUPTA, Vikas

Journal of clinical oncology, 2010-08, Vol.28 (23), p.3730-3738 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
Bem-estar Subjetivo em praticantes de exercício físico: estrutura e invariância fatorial
Bem-estar Subjetivo em praticantes de exercício físico: estrutura e invariância fatorial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Bem-estar Subjetivo em praticantes de exercício físico: estrutura e invariância fatorial

Romano, Amanda Rizzieri ; da Silva, Maynara Priscila Pereira ; Peixoto, Evandro Morais ; Valentini, Felipe

Motricidade, 2024-01, Vol.19 (4), p.1-24 [Periódico revisado por pares]

Ribeira de Pena: Edições Desafio Singular

Texto completo disponível

Citações Citado por
7
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm
Material Type:
Artigo 		Adicionar ao Meu Espaço

Long-Term Benefits of Tagraxofusp for Patients With Blastic Plasmacytoid Dendritic Cell Neoplasm

Pemmaraju, Naveen ; Sweet, Kendra L ; Stein, Anthony S ; Wang, Eunice S ; Rizzieri, David A ; Vasu, Sumithira ; Rosenblat, Todd L ; Brooks, Christopher L ; Habboubi, Nassir ; Mughal, Tariq I ; Kantarjian, Hagop ; Konopleva, Marina ; Lane, Andrew A

Journal of clinical oncology, 2022-09, Vol.40 (26), p.3032-3036 [Periódico revisado por pares]

United States: Wolters Kluwer Health

Texto completo disponível

Citações Citado por
8
CVD Risk Factors in the Ukrainian Roma and Meta-Analysis of Their Prevalence in Roma Populations Worldwide
CVD Risk Factors in the Ukrainian Roma and Meta-Analysis of Their Prevalence in Roma Populations Worldwide
Material Type:
Artigo 		Adicionar ao Meu Espaço

CVD Risk Factors in the Ukrainian Roma and Meta-Analysis of Their Prevalence in Roma Populations Worldwide

Zajc Petranović, Matea ; Rizzieri, Ashley Elizabeth ; Sivaraj, Dharshan ; Smolej Narančić, Nina ; Škarić-Jurić, Tatjana ; Celinšćak, Željka ; Stojanović Marković, Anita ; Peričić Salihović, Marijana ; Kalászi, Julia ; Kalászi, Marianna ; Lin, John Q. ; Mehta, Sanica ; Burleson, Jill ; Rizzieri, David A.

Journal of personalized medicine, 2021-11, Vol.11 (11), p.1138 [Periódico revisado por pares]

Basel: MDPI AG

Texto completo disponível

Citações Citado por
9
Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality
Material Type:
Artigo 		Adicionar ao Meu Espaço

Autologous or Reduced-Intensity Conditioning Allogeneic Hematopoietic Cell Transplantation for Chemotherapy-Sensitive Mantle-Cell Lymphoma: Analysis of Transplantation Timing and Modality

FENSKE, Timothy S ; ZHANG, Mei-Jie ; HOLMBERG, Leona A ; INWARDS, David J ; LAZARUS, Hillard M ; MAZIARZ, Richard T ; MUNKER, Reinhold ; PERALES, Miguel-Angel ; RIZZIERI, David A ; SCHOUTEN, Harry C ; SMITH, Sonali M ; WALLER, Edmund K ; CARRERAS, Jeanette ; WIRK, Baldeep M ; LAPORT, Ginna G ; MALONEY, David G ; MONTOTO, Silvia ; HARI, Parameswaran N ; AYALA, Ernesto ; BURNS, Linda J ; CASHEN, Amanda ; COSTA, Luciano J ; FREYTES, César O ; GALE, Robert P ; HAMADANI, Mehdi

Journal of clinical oncology, 2014-02, Vol.32 (4), p.273-281 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
10
Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Clofarabine Plus Cytarabine Compared With Cytarabine Alone in Older Patients With Relapsed or Refractory Acute Myelogenous Leukemia: Results From the CLASSIC I Trial

FADERL, Stefan ; WETZLER, Meir ; MARIS, Michael ; KOVACSOVICS, Tibor ; GOLDBERG, Stuart ; SEITER, Karen ; HARI, Parameswaran ; GREINER, Jochen ; VEY, Norbert ; RECHER, Christian ; RAVANDI, Farhad ; WANG, Eunice S ; RIZZIERI, David ; VASCONCELLES, Michael ; HUEBNER, Dirk ; KANTARJIAN, Hagop M ; SCHILLER, Gary ; JAGASIA, Madan ; STUART, Robert ; GANGULY, Siddhartha ; AVIGAN, David ; CRAIG, Michael ; COLLINS, Robert

Journal of clinical oncology, 2012-07, Vol.30 (20), p.2492-2499 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de1999  (7)
  2. 1999Até2004  (17)
  3. 2005Até2010  (199)
  4. 2011Até2017  (401)
  5. Após 2017  (249)
  6. Mais opções open sub menu

Idioma 

  1. Inglês  (859)
  2. Japonês  (122)
  3. Português  (39)
  4. Espanhol  (5)
  5. Francês  (4)
  6. Alemão  (2)
  7. Polonês  (2)
  8. Chinês  (1)
  9. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.